To recognize the progress achieved by Cytokinetics and the ALS community who supported their research, we interviewed and documented the journeys of ALS patients, researchers, scientists, and company leadership.
Resilience in the Fight Against ALS: One Company’s Journey of Courage, Commitment, and Ingenuity
For over two decades, biopharmaceutical company Cytokinetics has been at the forefront of the fight to discover new treatments for those with cardiovascular and neuromuscular diseases. To commemorate their efforts as the company moved on to new research, we documented their critical amyotrophic lateral sclerosis (ALS) research in a cloth-bound tribute to the company’s incredible milestones and involvement in the ALS community.
Honoring Patients and Progress
Patient Profiles
We celebrated ALS patients with vibrant profiles featuring customized illustrations, taking readers beyond the lab and into fundraising marches and the daily lives of patients.
Science Made Simple
We parsed down the complex science behind Cytokinetics’ research into accessible overviews and infographics that highlighted the company’s breakthroughs in ALS research.
